SAVANNAH MCKENZIE: Open Payments
NPI 1578088431 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 43 payments from 12 companies in 2025. Trend: 2023 $1,124 · 2024 $1,164 · 2025 $964
Food & beverage: $866Education: $98
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $227 |
| ABBVIE INC. | 14 | $216 |
| UCB, Inc. | 3 | $119 |
| LEO Pharma Inc. | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
| Janssen Biotech, Inc. | 2 | $46 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| STRATA Skin Sciences, Inc. | 3 | $25 |
| Lilly USA, LLC | 1 | $21 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, ADBRY, COSENTYX, Zoryve, TREMFYA, XTRAC.
Industry payments across MD — which companies pay providers there.
